Western Standard LLC Talaris Therapeutics, Inc. Transaction History

Western Standard LLC

  • $106 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.09 - $2.09 $639,264 - $1.23 Million
586,481 New
586,481 $1.1 Million

Others Institutions Holding TALS

# of Institutions
3
Shares Held
75.7K
Call Options Held
0
Put Options Held
0
View Full List

About Talaris Therapeutics, Inc.

TALS Quotes by TradingView
  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Western Standard LLC Portfolio

Follow Western Standard LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Standard LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Standard LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email